DeepSeek rattles Nvidia, OpenAI, and everyone else in the game. Plus, Frontier and Spirit work it out, Elon gets testy, and ...

Shares of newly public Metsera (MTSR), which is developing ultra-long-acting obesity drugs, rallied 54% following a $275M initial public offering. Read more here.

Your favorite toys and weight-loss drugs could be priced out of reach if Donald Trump is serious. Denmark’s defiant message ...